Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hsu

Showing results (821-830 of 846) with videos related to

Pageof 85
Sort By:
Cancer Genetics and Cytogenetics|January 20, 2000
A multicenter investigation with D-FISH BCR/ABL1 probesG Dewald, R Stallard, A Alsaadi, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2015
Practice parameter for the diagnosis and management of primary immunodeficiencyFrancisco A Bonilla, David A Khan, Zuhair K Ballas, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Journal of the American Heart Association|April 28, 2021
Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes StudyStephanie M Ware, James D Wilkinson, Muhammad Tariq, et al.
Arthritis Care & Research|October 14, 2022
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology AllianceManuel F Ugarte-Gil, Graciela S Alarcón, Andrea M Seet, et al.
The Journal of Clinical Investigation|December 10, 2013
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisAtsushi Terunuma, Nagireddy Putluri, Prachi Mishra, et al.
Cell|January 15, 2021
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.
RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.
Rheumatology (Oxford, England)|September 20, 2022
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination statusSinead Maguire, Samar Al-Emadi, Paula Alba, et al.
ACR Open Rheumatology|July 23, 2022
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance RegistryZara Izadi, Milena A Gianfrancesco, Alfredo Aguirre, et al.
Pageof 85

Showing results (821-830 of 846) with videos related to

Sort By:
Pageof 85
Cancer Genetics and Cytogenetics|January 20, 2000
A multicenter investigation with D-FISH BCR/ABL1 probesG Dewald, R Stallard, A Alsaadi, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2015
Practice parameter for the diagnosis and management of primary immunodeficiencyFrancisco A Bonilla, David A Khan, Zuhair K Ballas, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Journal of the American Heart Association|April 28, 2021
Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes StudyStephanie M Ware, James D Wilkinson, Muhammad Tariq, et al.
Arthritis Care & Research|October 14, 2022
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology AllianceManuel F Ugarte-Gil, Graciela S Alarcón, Andrea M Seet, et al.
The Journal of Clinical Investigation|December 10, 2013
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisAtsushi Terunuma, Nagireddy Putluri, Prachi Mishra, et al.
Cell|January 15, 2021
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.
RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.
Rheumatology (Oxford, England)|September 20, 2022
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination statusSinead Maguire, Samar Al-Emadi, Paula Alba, et al.
ACR Open Rheumatology|July 23, 2022
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance RegistryZara Izadi, Milena A Gianfrancesco, Alfredo Aguirre, et al.
Pageof 85